Myriad Genetics (MYGN) EPS (Basic) Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -33.21% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -4.60% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 10.70% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.57% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.47% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 21.28% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 253.03% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -0.71% |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | 18.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.70% |
| Dec 31, 2025 | 48.75% |
| Sep 30, 2025 | 12.30% |
| Jun 30, 2025 | -170.69% |
| Mar 31, 2025 | 83.86% |
| Dec 31, 2024 | -67.51% |
| Sep 30, 2024 | -40.51% |
| Jun 30, 2024 | -89.76% |
| Mar 31, 2024 | 17.69% |
| Dec 31, 2023 | 21.76% |
| Sep 30, 2023 | -55.36% |
| Jun 30, 2023 | -24.27% |
| Mar 31, 2023 | 24.39% |
| Dec 31, 2022 | -67.83% |
| Sep 30, 2022 | -15.37% |
| Jun 30, 2022 | -44.22% |
| Mar 31, 2022 | -69.72% |
| Dec 31, 2021 | -65.10% |
| Sep 30, 2021 | 220.75% |
| Jun 30, 2021 | -31.73% |